KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Exelixis (EXEL) EBITDA Margin: 2010-2025

Historic EBITDA Margin for Exelixis (EXEL) over the last 16 years, with Oct 2025 value amounting to 39.57%.

  • Exelixis' EBITDA Margin rose 1435.00% to 39.57% in Q4 2025 from the same period last year, while for Oct 2025 it was 34.97%, marking a year-over-year increase of 984.00%. This contributed to the annual value of 27.88% for FY2025, which is 1854.00% up from last year.
  • Latest data reveals that Exelixis reported EBITDA Margin of 39.57% as of Q4 2025, which was up 5.29% from 37.58% recorded in Q3 2025.
  • Exelixis' EBITDA Margin's 5-year high stood at 43.30% during Q2 2024, with a 5-year trough of -11.34% in Q4 2022.
  • Its 3-year average for EBITDA Margin is 22.91%, with a median of 25.22% in 2024.
  • Over the last 5 years, Exelixis' EBITDA Margin had its largest YoY gain of 3,414bps in 2021, and its largest YoY loss of 2,498bps in 2021.
  • Over the past 5 years, Exelixis' EBITDA Margin (Quarterly) stood at 15.72% in 2021, then spiked by 435bps to -11.34% in 2022, then soared by 2,839bps to 17.05% in 2023, then surged by 2,895bps to 25.22% in 2024, then soared by 1,435bps to 39.57% in 2025.
  • Its last three reported values are 39.57% in Q4 2025, 37.58% for Q3 2025, and 33.64% during Q2 2025.